Literature DB >> 33671961

Feline Leukemia Virus p27 Antigen Concentration and Proviral DNA Load Are Associated with Survival in Naturally Infected Cats.

Melissa J Beall1, Jesse Buch1, Genevieve Clark1, Marko Estrada1, Andrei Rakitin1, Natascha T Hamman2, Monica K Frenden2, Ellen P Jefferson2, E Susan Amirian2, Julie K Levy3.   

Abstract

Longitudinal studies of cats naturally infected with feline leukemia virus (FeLV) are important for understanding disease outcomes. Levels of p27 antigen and copy numbers of proviral DNA have been associated with FeLV-infection courses. The purpose of this prospective study was to establish cutoff values for p27 antigen concentration and proviral DNA load that distinguished high positive from low positive groups of cats and to evaluate an association with survival. At enrollment, 254 cats were tested by point-of-care and microtiter plate enzyme-linked immunosorbent assays (ELISAs) for p27 antigen and real-time polymerase chain reaction (PCR) for proviral DNA. The 127 positive cats were retested monthly for six months and monitored for survival over the four-year study. A receiver operating characteristic-based analysis of samples with concordant or discordant qualitative results for p27 antigen and proviral DNA was used to establish cutoff values, and when applied to test results at enrollment for classifying cats as high positive or low positive, a significant difference in survival was observed. High positive cats had a median survival of 1.37 years (95% CI 0.83-2.02) from time of enrollment, while most low positive cats were still alive (93.1% survival). Quantitative results for p27 antigen concentration and proviral DNA load were highly correlated with survival times in FeLV-infected cats.

Entities:  

Keywords:  FeLV; diagnostics; longitudinal; progressive; quantitative; regressive; survival

Mesh:

Substances:

Year:  2021        PMID: 33671961      PMCID: PMC7919025          DOI: 10.3390/v13020302

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  43 in total

1.  A VIRUS-LIKE PARTICLE ASSOCIATED WITH LEUKEMIA (LYMPHOSARCOMA).

Authors:  W F JARRETT; E M CRAWFORD; W B MARTIN; F DAVIE
Journal:  Nature       Date:  1964-05-09       Impact factor: 49.962

2.  Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.

Authors:  M A Gomes-Keller; R Tandon; E Gönczi; M L Meli; R Hofmann-Lehmann; H Lutz
Journal:  Vet Microbiol       Date:  2005-11-21       Impact factor: 3.293

3.  Transmission of feline leukaemia virus in the milk of a non-viraemic cat.

Authors:  A M Pacitti; O Jarrett; D Hay
Journal:  Vet Rec       Date:  1986-04-05       Impact factor: 2.695

4.  Seroprevalences of feline leukemia virus and feline immunodeficiency virus infection in cats in the United States and Canada and risk factors for seropositivity.

Authors:  Amie N Burling; Julie K Levy; H Morgan Scott; Michael M Crandall; Sylvia J Tucker; Erin G Wood; Jessie D Foster
Journal:  J Am Vet Med Assoc       Date:  2017-07-15       Impact factor: 1.936

5.  Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes.

Authors:  A Katrin Helfer-Hungerbuehler; Stefan Widmer; Yvonne Kessler; Barbara Riond; Felicitas S Boretti; Paula Grest; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Virus Res       Date:  2014-12-30       Impact factor: 3.303

6.  Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction.

Authors:  Mark D G Pinches; Christopher R Helps; Tim J Gruffydd-Jones; Kathy Egan; Oswald Jarrett; Séverine Tasker
Journal:  J Feline Med Surg       Date:  2006-07-24       Impact factor: 2.015

7.  Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.

Authors:  A Katrin Helfer-Hungerbuehler; Valentino Cattori; Felicitas S Boretti; Pete Ossent; Paula Grest; Manfred Reinacher; Manfred Henrich; Eva Bauer; Kim Bauer-Pham; Eva Niederer; Edgar Holznagel; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2010-02-19       Impact factor: 4.602

8.  Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27.

Authors:  H Lutz; N C Pedersen; R Durbin; G H Theilen
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

9.  Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  Time-dependent ROC curve analysis in medical research: current methods and applications.

Authors:  Adina Najwa Kamarudin; Trevor Cox; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2017-04-07       Impact factor: 4.615

View more
  3 in total

1.  Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008-2019).

Authors:  Amelie Pare; Alexandre Ellis; Tristan Juette
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

2.  Special Issue: Viral Infections in Companion Animals.

Authors:  Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2022-02-04       Impact factor: 5.818

3.  Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.

Authors:  Yasmin A Parr; Melissa J Beall; Julie K Levy; Michael McDonald; Natascha T Hamman; Brian J Willett; Margaret J Hosie
Journal:  Viruses       Date:  2021-03-07       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.